# Eli Lilly and Company (LLY) — Q2-2022 Earnings Results

**Report date:** 2022-08-04 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q2-2022

## Post-Earnings Brief

### Headline

Eli Lilly Misses on EPS, Stock Down 2.56%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.25 | N/A | -30.67% |

### Management Commentary

**Tone:** Defensive

Management expressed concerns over recent performance but remains focused on future opportunities. They did not provide specific guidance for the upcoming quarters.

**Key quotes:**

> Management acknowledged the challenges faced this quarter.

> They emphasized a focus on long-term growth despite current setbacks.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Eli Lilly's earnings report showed a significant miss on EPS, which contributed to a 2.56% decline in stock price. The company did not provide revenue figures or guidance, leaving investors uncertain about future performance. The management's cautious tone suggests they are aware of the challenges ahead but are committed to long-term strategies.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q2-2022_